PMID- 23698354
OWN - NLM
STAT- MEDLINE
DCOM- 20130918
LR  - 20220408
IS  - 1539-3704 (Electronic)
IS  - 0003-4819 (Linking)
VI  - 159
IP  - 1
DP  - 2013 Jul 2
TI  - Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement.
PG  - 51-60
LID - 10.7326/0003-4819-159-1-201307020-00645 [doi]
AB  - DESCRIPTION: Update of the 2005 U.S. Preventive Services Task Force (USPSTF) 
      recommendation statement on screening for HIV. METHODS: The USPSTF reviewed new 
      evidence on the effectiveness of treatments in HIV-infected persons with CD4 
      counts greater than 0.200 x 109 cells/L; effects of screening, counseling, and 
      antiretroviral therapy (ART) use on risky behaviors and HIV transmission risk; 
      and long-term cardiovascular harms of ART. POPULATION: These recommendations 
      apply to adolescents, adults, and pregnant women. RECOMMENDATION: The USPSTF 
      recommends that clinicians screen adolescents and adults aged 15 to 65 years for 
      HIV infection. Younger adolescents and older adults who are at increased risk 
      should also be screened. (Grade A recommendation)The USPSTF recommends that 
      clinicians screen all pregnant women for HIV, including those who present in 
      labor who are untested and whose HIV status is unknown. (Grade A recommendation).
FAU - Moyer, Virginia A
AU  - Moyer VA
AD  - U.S. Preventive Services Task Force, Rockville, Maryland
CN  - U.S. Preventive Services Task Force*
LA  - eng
PT  - Journal Article
PT  - Practice Guideline
PT  - Research Support, U.S. Gov't, P.H.S.
PL  - United States
TA  - Ann Intern Med
JT  - Annals of internal medicine
JID - 0372351
RN  - 0 (Anti-Retroviral Agents)
SB  - IM
CIN - Ann Intern Med. 2013 Jul 2;159(1):63-4. PMID: 23698261
SPIN- Ann Intern Med. 2013 Jul 2;159(1):I-36. PMID: 23817719
CIN - J Am Osteopath Assoc. 2013 Jul;113(7):505. PMID: 23843371
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Anti-Retroviral Agents/adverse effects/therapeutic use
MH  - CD4 Lymphocyte Count
MH  - Cardiovascular Diseases/chemically induced
MH  - Cost-Benefit Analysis
MH  - Counseling
MH  - Female
MH  - HIV Infections/*diagnosis/*drug therapy/prevention & control/transmission
MH  - Humans
MH  - *Mass Screening/economics
MH  - Middle Aged
MH  - Pregnancy
MH  - Risk Assessment
MH  - Risk-Taking
MH  - Young Adult
FIR - Moyer, Virginia A
IR  - Moyer VA
FIR - LeFevre, Michael L
IR  - LeFevre ML
FIR - Siu, Albert L
IR  - Siu AL
FIR - Peters, James J
IR  - Peters JJ
FIR - Baumann, Linda Ciofu
IR  - Baumann LC
FIR - Bibbins-Domingo, Kirsten
IR  - Bibbins-Domingo K
FIR - Curry, Susan J
IR  - Curry SJ
FIR - Ebell, Mark
IR  - Ebell M
FIR - Flores, Glenn
IR  - Flores G
FIR - Garcia, Francisco A R
IR  - Garcia FA
FIR - Cantu, Adelita Gonzales
IR  - Cantu AG
FIR - Grossman, David C
IR  - Grossman DC
FIR - Herzstein, Jessica
IR  - Herzstein J
FIR - Nicholson, Wanda K
IR  - Nicholson WK
FIR - Owens, Douglas K
IR  - Owens DK
FIR - Phillips, William R
IR  - Phillips WR
FIR - Pignone, Michael P
IR  - Pignone MP
FIR - Isham, George
IR  - Isham G
FIR - Wilt, Timothy J
IR  - Wilt TJ
EDAT- 2013/05/24 06:00
MHDA- 2013/09/21 06:00
CRDT- 2013/05/24 06:00
PHST- 2013/05/24 06:00 [entrez]
PHST- 2013/05/24 06:00 [pubmed]
PHST- 2013/09/21 06:00 [medline]
AID - 1682314 [pii]
AID - 10.7326/0003-4819-159-1-201307020-00645 [doi]
PST - ppublish
SO  - Ann Intern Med. 2013 Jul 2;159(1):51-60. doi: 
      10.7326/0003-4819-159-1-201307020-00645.